B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages
- 15 January 2007
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 313 (2), 331-340
- https://doi.org/10.1016/j.yexcr.2006.10.015
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Role of transcription factors in commitment and differentiation of early B lymphoid cellsSeminars in Immunology, 2006
- Transcriptional Control of Early B Cell DevelopmentAnnual Review of Immunology, 2004
- Pax5 Activates Immunoglobulin Heavy Chain V to DJ Rearrangement in Transgenic ThymocytesThe Journal of Experimental Medicine, 2004
- Pax5 inducesV-to-DJrearrangements and locus contraction of theimmunoglobulin heavy-chaingeneGenes & Development, 2004
- Pax5is required for recombination of transcribed, acetylated, 5′ IgH V gene segmentsGenes & Development, 2003
- A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesisOncogene, 2002
- Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.JCI Insight, 1997
- The B/macrophage cell: an elusive link between CD5+ B lymphocytes and macrophagesImmunology Today, 1996
- Requirement of Transcription Factor PU.1 in the Development of Multiple Hematopoietic LineagesScience, 1994
- SELECTIVE TRIGGERING OF HUMAN T AND B LYMPHOCYTES IN VITRO BY POLYCLONAL MITOGENSThe Journal of Experimental Medicine, 1974